Biotech Archives - Page 41 of 57 - Life Sciences Times

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

THIS WEEK'S STORIES

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

Aya Healthcare Appoints Emily Hazen as CEO, Founder Alan Braynin to Serve as Strategic Advisor

May 5, 2025

Align Technology Launches New $1 Billion Stock Buyback Program

May 6, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Lightcast Unveils Envisia™ Single-Cell Analysis Platform for Antibody Discovery at PEGS Boston

Twist Bioscience and Ginkgo Bioworks Revise Collaboration, Granting Twist Key Long DNA Technology License

Univercells Technologies Launches scale-X™ Nitro Controller to Accelerate Large-Scale Viral Therapy Manufacturing

INBRAIN Neuroelectronics Secures €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene Brain-Computer Interfaces

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

Most Read

GSK and Lifetime Team Up to Raise Awareness of Meningitis Through New Original Movie

What’s a fair price for a drug that’s never developed?

QuantHealth Launches First Clinical AI Foundation Model for Life Sciences Industry

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

EDITOR PICKS

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

THIS WEEK'S STORIES

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

Aya Healthcare Appoints Emily Hazen as CEO, Founder Alan Braynin to Serve as Strategic Advisor

Align Technology Launches New $1 Billion Stock Buyback Program

POPULAR CATEGORY

ABOUT US

FOLLOW US